Zobrazeno 1 - 10 of 94 pro vyhledávání: '"Hector R. Nava"'
1
Complete pathologic response is independent of the timing of esophagectomy following neoadjuvant chemoradiation for esophageal cancer
Autor: Raed M. Alnaji, Hector R. Nava, Emmanuel Gabriel, Steven N. Hochwald, Moshim Kukar, Smit Singla, William Du, Kristopher Attwood
Publikováno v: Journal of Gastrointestinal Oncology. 9:73-79
Background: The relationship of complete pathologic response (cPR) with the timing of esophagectomy after neoadjuvant chemoradiation (nCRT) is not well defined. We sought to determine if a delay in esophagectomy after nCRT would result in increased l
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c2a90eabd6dcc270defb6c2cfc07f28b
https://doi.org/10.21037/jgo.2017.09.11
Zobrazit plný text záznamu
2
Photodynamic therapy (PDT) using HPPH for the treatment of precancerous lesions associated with barrett's esophagus
Autor: Michele T. Cooper, Barbara W. Henderson, Shyam Allamaneni, Hector R. Nava, Gregory E. Wilding, Wei Tan, Thomas J. Dougherty
Publikováno v: Lasers in Surgery and Medicine. 43:705-712
Background and Objectives Photodynamic therapy (PDT) with porfimer sodium, FDA approved to treat premalignant lesions in Barrett’s esophagus, causes photosensitivity for 6-8 weeks. HPPH (2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a) shows minim
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::f92ec9f057b2bff10764d40fa3988657
https://doi.org/10.1002/lsm.21112
Zobrazit plný text záznamu
3
Capecitabine, Oxaliplatin and Radiotherapy: A Phase IB Neoadjuvant Study for Esophageal Cancer with Gene Expression Analysis
Autor: Joshua Prey, Lakshmi Pendyala, C. E. Nwogu, Kimberly R. Clark, Gary Y. Yang, Michael Schiff, Patrick F. Smith, Milind Javle, Gregory E. Wilding, Hector R. Nava, Linda O'Malley, Charles LeVea, Sanjay Vinjamaram
Publikováno v: Cancer Investigation. 27:193-200
Purpose: To determine the maximal tolerated dose of capecitabine with oxaliplatin + radiotherapy in a phase I study of localized esophageal cancer. Patients and Methods: Oxaliplatin (85 mg/m2) administered on days 1, 15, and 29. Capecitabine administ
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae260f2827b920a482f8fcfebabfa41c
https://doi.org/10.1080/07357900802172093
Zobrazit plný text záznamu
4
Squamous Overgrowth Is Not a Safety Concern for Photodynamic Therapy for Barrett's Esophagus With High-Grade Dysplasia
Autor: Mary P, Bronner, Bergein F, Overholt, Shari L, Taylor, Rodger C, Haggitt, Kenneth K, Wang, J Steven, Burdick, Charles J, Lightdale, Michael, Kimmey, Hector R, Nava, Michael V, Sivak, Norman, Nishioka, Hugh, Barr, Marcia I, Canto, Norman, Marcon, Marcos, Pedrosa, Michael, Grace, Michelle, Depot, Roxan, Saidi
Publikováno v: Gastroenterology. 136:56-64
Background & Aims Photodynamic therapy with porfimer sodium combined with acid suppression (PHOPDT) is used to treat patients with Barrett's esophagus (BE) with high-grade dysplasia (HGD). A 5-year phase 3 trial was conducted to determine the extent
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::94bc4f7a1b172f4387b54542dcd02b8e
https://doi.org/10.1053/j.gastro.2008.10.012
Zobrazit plný text záznamu
5
Concurrent Oxaliplatin, 5-Fluorouracil, and Radiotherapy in the Treatment of Locally Advanced Esophageal Carcinoma
Autor: Amitkumar Pande, Hector R. Nava, Milind Javle, Manpreet K. Chadha, C. E. Nwogu, Jeffrey Lombardo, Brigid M. O'Connor, Gary Y. Yang
Publikováno v: The Cancer Journal. 13:119-124
Purpose: The combination of oxaliplatin, 5-fluorouracil, and leucovorin with concurrent radiotherapy was demonstrated to be a safe regimen for locally advanced esophageal carcinoma in a prior phase I study. We now report the efficacy data for 42 pati
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e2a03a165a812448ec42829ad8abadf
https://doi.org/10.1097/ppo.0b013e318046ee1a
Zobrazit plný text záznamu
6
Pathologic Complete Response Is an Independent Predictor of Improved Survival Following Neoadjuvant Chemoradiation for Esophageal Adenocarcinoma
Autor: Moshim Kukar, Kristopher Attwood, Usha Malhotra, Raed M. Alnaji, Emmanuel Gabriel, Hector R. Nava, William Du, Steven N. Hochwald, Smit Singla
Publikováno v: Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract. 20(9)
Reports of improved survival in patients with pathologic complete response (pCR) to neoadjuvant therapy for esophageal and gastroesophageal junction (GEJ) adenocarcinoma is extrapolated from heterogeneous studies that include squamous cell histology.
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2769e0e2eb9b645c688e1d2c87bcb451
https://pubmed.ncbi.nlm.nih.gov/27260525
Zobrazit plný text záznamu
8
The introducer technique is the optimal method for placing percutaneous endoscopic gastrostomy tubes in head and neck cancer patients
Autor: Michael Schiff, Wesley L. Hicks, Jason M. Foster, Hector R. Nava, Peter Filocamo, Thorn Loree, Nestor R. Rigual, John F. Gibbs, Judy L. Smith
Publikováno v: Surgical Endoscopy. 21:897-901
Percutaneous endoscopic gastrostomy (PEG) tubes are often placed in head and neck cancer patients to provide nutritional support, but studies have found the complication rates to be higher than other subsets of patients who undergo PEG placement. Com
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2853a8dd916397da3a9353ed9c0eb267
https://doi.org/10.1007/s00464-006-9068-9
Zobrazit plný text záznamu
9
Clinical Pharmacokinetics of the PDT Photosensitizers Porfimer Sodium (Photofrin), 2-[1-Hexyloxyethyl]-2-Devinyl Pyropheophorbide-a (Photochlor) and 5-ALA-Induced Protoporphyrin IX
Autor: William R. Greco, Gregory M. Loewen, David A. Bellnier, Allan R. Oseroff, Thomas J. Dougherty, Hector R. Nava
Publikováno v: Lasers in Surgery and Medicine. 38:439-444
Background and Objectives Photodynamic therapy (PDT) uses a photosensitizer activated by light, in an oxygen-rich environment, to destroy malignant tumors. Clinical trials of PDT at Roswell Park Cancer Institute (RPCI) use the photosensitizers Photof
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a737f1cf35a173fdd37f14718348980
https://doi.org/10.1002/lsm.20340
Zobrazit plný text záznamu
10
Risk factors associated with earlier age of onset in familial pancreatic carcinoma
Autor: David G. Sheldon, John F. Gibbs, Hector R. Nava, Milind Javle, Ashwani Rajput, Judy L. Smith, Boris W. Kuvshinoff, Ted A. James
Publikováno v: Cancer. 101:2722-2726
BACKGROUND An estimated 5–10% of all pancreatic adenocarcinomas have a hereditary association. The objective of the current study was to characterize the clinical and pathologic features of familial pancreatic carcinoma and to determine potential d
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b6fcf90306c63a5387c1b88e717ebb5b
https://doi.org/10.1002/cncr.20700
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje